Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Site
Birmingham Alabama 35233

Does type 2 diabetes run in your family? Then sit up and take notice

Research Site
Huntsville Alabama

A Phase 3 clinical study of Ertugliflozin for patients with Type 2 Diabetes Mellitus with Stage 3 Chronic Kidney Disease who have inadequate glycemic control on metformin

Boehringer Ingelheim Investigational Site
Mobile Alabama 36601

Clinical trial for Diabetes Mellitus, Type 2

View More ▼

UPDATED

Anniston Alabama

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes

UPDATED

Birmingham Alabama 35233-1711

A clinical research study for the treatment of Type 2 Diabetes Mellitus

UPDATED

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

UPDATED

Birmingham Alabama 35294-2041

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

UPDATED

Birmingham Alabama 35233

A clinical trial to evaluate treatments using liraglutide, placebo and metformin for patients with Diabetes or Diabetes Mellitus, Type 2

UPDATED

Birmingham Alabama 35233-1711

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

UPDATED

Birmingham Alabama 35233-1711

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

UPDATED

Birmingham Alabama 35235

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Birmingham Alabama 35211

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study of Empagliflizon low dose, placebo and Empagliflizon high dose to evaluate Diabetes Mellitus, Type 2 or Hypertension

UPDATED

Fort Payne Alabama 35967

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

UPDATED

Fort Payne Alabama 35967

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

UPDATED

Gulf Shores Alabama 36542

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Guntersville Alabama 35976

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Huntsville Alabama 35801

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

UPDATED

Huntsville Alabama

A Phase 4 clinical study for patients with Diabetes Mellitus, Type 2

UPDATED

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Huntsville Alabama

Patients are needed to participate in a clinical research study of Empagliflizon low dose, placebo and Empagliflizon high dose to evaluate Diabetes Mellitus, Type 2 or Hypertension

UPDATED

Mobile Alabama

Patients are needed to participate in a clinical research study of Empagliflizon low dose, placebo and Empagliflizon high dose to evaluate Diabetes Mellitus, Type 2 or Hypertension

UPDATED

Mobile Alabama

Patients are needed to participate in a clinical research study of Empagliflizon low dose, placebo and Empagliflizon high dose to evaluate Diabetes Mellitus, Type 2 or Hypertension

UPDATED

Montgomery Alabama 36104

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Montgomery Alabama 36109

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Muscle Shoals Alabama

A Phase 4 clinical study for patients with Diabetes Mellitus, Type 2

UPDATED

Saraland Alabama 36571

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Scottsboro Alabama

A Phase 4 clinical study for patients with Diabetes Mellitus, Type 2

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

Alexander City Alabama

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Alexander City Alabama

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Anniston Alabama 36207

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus (T2DM)

Anniston Alabama 36207

A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 2

Anniston Alabama 36207

Patients are needed to participate in a clinical research study evaluating Met DR, Met IR and Placebo for the treatment of Type 2 Diabetes Mellitus

Athens Alabama

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Athens Alabama

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Birmingham Alabama

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Birmingham Alabama 35216

A clinical research study of Sitagliptin 100 mg, DS-8500a 25mg and placebo for the treatment of Type 2 Diabetes Mellitus

Birmingham Alabama

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Birmingham Alabama 35211

A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 2

Birmingham Alabama

A Phase 3 clinical study for patients with Type 2 Diabetes or Comparative Effectiveness of Glycemia-lowering Medications

Birmingham Alabama 35235

Patients are needed to participate in a clinical research study evaluating ITCA 650 20/60 mcg/day and ITCA 650 60 mcg/day for the treatment of Diabetes Mellitus, Type 2

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating Met DR, Met IR and Placebo for the treatment of Type 2 Diabetes Mellitus

Birmingham Alabama 35216

Patients are needed to participate in a clinical research study evaluating Met DR, Met IR and Placebo for the treatment of Type 2 Diabetes Mellitus

Birmingham Alabama 35209

Patients are needed to participate in a clinical research study evaluating Met DR, Met IR and Placebo for the treatment of Type 2 Diabetes Mellitus

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating placebo and exenatide for the treatment of Type 2 Diabetes

Birmingham Alabama 35235

Patients are needed to participate in a clinical research study of Albiglutide 30 mg, Albiglutide 50 mg and Albiglutide matching placebo to evaluate Diabetes Mellitus, Type 2